Optimization of virtual reality for pain management of percutaneous transhepatic biliary drainage
Not Applicable
Recruiting
- Conditions
- Neoplasms
- Registration Number
- KCT0006775
- Lead Sponsor
- niversity of Ulsan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Patients 19 years of age or older undergoing PTBD who voluntarily consented in writing to participate in this study using VR therapy
Exclusion Criteria
Patients with cognitive decline, vision (including color recognition) or hearing loss, or facial defects, injuries or malformations, brain damage, or brain metastases that are not suitable for VR application
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Analgesic dosage (mean total milligrams of morphine equivalent, MME) and patient's subjective pain scale assessed by numeric rating scale (NRS)
- Secondary Outcome Measures
Name Time Method Changes in total bilirubin levels before and after PTBD
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does virtual reality modulate pain pathways during PTBD in neoplasms via KCT0006775?
What is the comparative effectiveness of VR vs pharmacological analgesia in PTBD for biliary obstruction?
Which biomarkers predict response to VR-based pain management in PTBD for cholangiocarcinoma?
What adverse effects are associated with VR use during PTBD and how are they managed in cancer patients?
Are there combination therapies with VR for pain relief in PTBD for unresectable pancreatic cancer?